CN Patent

CN102112112A — 用于治疗耳部病症的受控释放抗微生物组合物和方法

Assigned to Otonomy Inc · Expires 2011-06-29 · 15y expired

What this patent protects

本文揭示用抗微生物剂组合物和调配物治疗耳部疾病或病况的组合物和方法，其中通过将所述抗微生物剂组合物和调配物直接施加至靶定耳部结构上或灌注至所述靶定耳部结构中来将所述组合物和调配物局部投与患有耳部疾病或病况的个体。

USPTO Abstract

本文揭示用抗微生物剂组合物和调配物治疗耳部疾病或病况的组合物和方法，其中通过将所述抗微生物剂组合物和调配物直接施加至靶定耳部结构上或灌注至所述靶定耳部结构中来将所述组合物和调配物局部投与患有耳部疾病或病况的个体。

Drugs covered by this patent

Patent Metadata

Patent number
CN102112112A
Jurisdiction
CN
Classification
—
Expires
2011-06-29
Drug substance claim
No
Drug product claim
No
Assignee
Otonomy Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.